Positron Emission Tomography/Computed Tomography Transformation of Oncology: Melanoma and Skin Malignancies
Details
Publication Year 2024-04,Volume 19,Issue #2,Page 231-248
Journal Title
PET Clinics
Publication Type
Review
Abstract
Skin cancers are the most common cancers, with melanoma resulting in the highest cause of death in this category. Accurate clinical, histologic, and imaging staging with fludeoxyglucose positron emission tomography (FDG PET) is most important to guide patient management. Whilst surgical excision with clear margins is the gold-standard treatment for primary cutaneous melanoma, targeted therapies have generated remarkable and rapid clinical responses in melanoma, for which FDG PET also plays an important role in assessment of treatment response and post-therapy surveillance. Non-FDG PET tracers, advanced PET technology, and PET radiomics may potentially change the landscape of the utilization of PET in the imaging of patients with cutaneous malignancies.
Publisher
Elsevier
Keywords
Humans; *Melanoma/diagnostic imaging; *Skin Neoplasms/diagnostic imaging/therapy; Fluorodeoxyglucose F18; Neoplasm Staging; Positron Emission Tomography Computed Tomography/methods; Positron-Emission Tomography/methods; Radiopharmaceuticals; Cutaneous malignancies; Fdg-pet; Immunotherapy; Melanoma; Pet; PET radiomics
Department(s)
Medical Oncology
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2024-04-04 03:09:37
Last Modified: 2024-04-04 03:11:20

© 2024 The Walter and Eliza Hall Institute of Medical Research. Access to this website is subject to our Privacy Policy and Terms of Use

An error has occurred. This application may no longer respond until reloaded. Reload 🗙